Pharma tech firms announce global MES partnership
Zenith Technologies and Werum IT Solutions to help improve pharma companies' production performance.
Zenith Technologies and Werum IT Solutions have formed a global partnership to support pharmaceutical companies with the implementation of manufacturing execution system (MES) technology to improve production performance.
The collaboration brings together Werum IT Solution’s MES PAS-X software, which is designed to increase efficiency, improve productivity and meet regulatory requirements during pharmaceutical manufacturing, with Zenith Technologies’ ability to integrate systems and provide on-the-ground automation technical support. The PAS-X software is used by the majority of the world’s top 30 pharmaceutical and biotech companies but also by many regional and mid-sized manufacturers.
The partnership, which was signed at Werum’s headquarters in Lüneburg, Germany, makes Zenith Technologies an Endorsed Service Partner of Werum IT Solutions in both the US and Europe. Zenith Technologies will support Werum customers during all MES implementation phases, delivering comprehensive support and consultancy services that complement Werum’s manufacturing IT solutions.
“We are delighted to partner with Zenith Technologies,” says Torsten Isenberg, Senior Director Services at Werum IT Solutions GmbH. “As an Endorsed Service Partner, Zenith Technologies has the knowledge and experience required to be part of our PAS-X service partner program. Our main objective is to ensure a high level of support for our customers through reliable, experienced and certified partners.”
Brendan O’ Regan, chairman and founder, Zenith Technologies, adds: “Given our combined expertise in automation and the similarities in our customer base, the collaboration represents a strategic move for both companies. By combining Werum’s MES technology with our technical implementation experience, we can provide customers with a high quality of service, training and local level support, helping them to remain both compliant and competitive. We are continually investing in training and working together with Werum and other solution providers to ensure we stay ahead with the latest technology.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance